Media fails to cover harms of early diagnostic testing: study Researchers fear a lack of risk–benefit analysis may be contributing to overdiagnosis.
COVID vaccines and cancer patients Cancer Australia has developed a set of frequently asked questions designed to help address patient concerns.
Calls to reduce breast cancer screening age spark overdiagnosis fears New research suggests screening from age 40 has better outcomes for reducing breast cancer mortality. But is that really the case?
Study identifies four main comorbidities associated with COVID deaths Coronavirus patients with cancer, chronic kidney disease, diabetes or hypertension were found to be most at risk of death.
Provider portal to refresh cancer screening process The National Cancer Screening Register’s new eHealth portal also includes clinical software integration.
Clinical update to National Cervical Screening Program guidelines Important pathway changes for women at intermediate risk of significant cervical abnormality come into effect on 1 February.
Aspirin linked to better survival rates for bladder and breast cancer The tide has turned against aspirin for cancer prevention – but new research suggests there may still be a role after diagnosis.
New breast cancer research has ‘immediate implications’ The study has produced fresh evidence about the use of androgens as a potential treatment for oestrogen receptor-positive breast cancer.
People with cancer not making advance care plans with their GP A new survey suggests less than 3% discuss end-of-life care with their doctor.
PBS to provide access to life-saving MS and cancer medicines New medicines for multiple sclerosis and various cancers will be available on the Pharmaceutical Benefits Scheme from 1 November.